🤶Recurrence Breast cancer Flashcards
📩 If you have any questions or notice any errors, please feel free to email ericgansy18@gmail.com (7 cards)
What is Recurrent Breast cancer?
LOCAL Recurrence - reappearance of cancer in ipsilateral region of mastectomy site or remnant breast.
REGIONAL Recurrence - tumor recurrence involving axillary, supra & infraclavicular LN.
METASTASIS - reappearance of cancer at outside ipsilateral locoregional area (include contralateral breast & axilla) ± locoregional recurrence.
Incidence of Recurrent Breast cancer
Mastectomy: 5 – 10% in 10 years
BCT: 10 – 15% and occur later than MAC
BCS: 35% risk
Presentation of Recurrent Breast cancer
Local recurrence (new tumor or true recurrence)
- Diagnosed clinically : Asymptomatic cutaneous/ S.C nodules at or near mastectomy site. Nodules may be multiple / diffuse involvement of chest wall skin.
- Diagnosed by MMG : 50% in BCS patients.
Regional recurrence - 1/3rd will have concurrent regional recurrence
- Asymptomatic or Brachial plexopathy, severe lymphoedema
Metastatic
- Visceral
- Liver - Jaundice, hepatomegaly, ascites, coagulopathy
- Lung - Pleural effusion
- Cardiac - Pericardial effusion
- Brain - Confusion, Seizure, headache, photophobia
- Bone (SRE) - Bone pain, pathological fracture, spinal cord compression, hypercalcemia, viscera crisis (viscera mets with end organ damage).
How to manage recurrent Breast cancer?
Review previous treatment - HPE, Staging, Treatment, Adjuvant / Neoadjuvant therapy
Restage !
- Locoregional
- Breast : Biopsy (HPE, ER/PR, HER2 as tumor biology may change), MMG, USG
- Axilla : USG axilla
- Metastatic
- Visceral : CT TAP/ MRI, PET/CT, Bloods (LFT, FBC, RP)
-
Bone : Bone scan recommended If +ve CT or MRI to look for bone destruction and to differentiate from radiation induced fibrosis.
- Serum Ca, Alb, PO4.
- Operability : ECOG, ASA, ECHO, Lung function test
Overview of Recurrent breast cancer management
- MDT
- Individualized approach should be offered.
Factor affecting prognosis are the risk factors for recurrence.
Despite aggressive local treatment, large number of patients eventually develops metastases.
- Patient factors: Age ≤ 35 years old.
- Disease: Tumor character (HER2 +, ER/PR –ve, High grade, size) Initial stage (high N), current stage (multiple site, visceral involvement)
- Treatment: Extent of primary surgery (margin involved), no adjuvant treatment, short DFS ≤ 2 years.
Recurrece of contralateral breast
- Not considered local, Consider another primary tumor or metastatic disease.
Signs suggestive of primary tumor
- HPE different from primary tumor
- Long DFS ≥ 5 years.
- No locoregional or metastatic symptoms.